| A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT00806923) | Hoffmann-La Roche | 2005-02-01 |
| A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) (NCT01095835) | Hoffmann-La Roche | 2005-02-01 |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors or Hematologic Malignancies (NCT02564094) | Hoffmann-La Roche | 2005-02-01 |
| PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia (NCT02598453) | Hoffmann-La Roche | 2005-01-01 |
| A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer (NCT02576964) | Hoffmann-La Roche | 2005-01-01 |
| An Analysis of Treatment Patterns and Outcomes for Basal Cell Carcinoma (BCC) Cancer Participants (NCT02100111) | Hoffmann-La Roche | 2005-01-01 |
| A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA) (NCT00106535) | Hoffmann-La Roche | 2005-01-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer (NCT00112918) | Hoffmann-La Roche | 2004-12-01 |
| A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis. (NCT00377741) | Hoffmann-La Roche | 2004-12-01 |
| Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (NCT02733419) | Hoffmann-La Roche | 2004-12-01 |
| A Study of Capecitabine (Xeloda) as First-Line Chemotherapy in Participants With Metastatic Nasopharyngeal Cancer (NCT02608073) | Hoffmann-La Roche | 2004-11-01 |
| An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00949910) | Hoffmann-La Roche | 2004-11-01 |
| Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients (NCT02686619) | Hoffmann-La Roche | 2004-11-01 |
| A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease (NCT02564107) | Hoffmann-La Roche | 2004-11-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV) (NCT02570191) | Hoffmann-La Roche | 2004-11-01 |
| A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia (NCT00090753) | Hoffmann-La Roche | 2004-10-01 |
| PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C. (NCT00087633) | Hoffmann-La Roche | 2004-10-01 |
| Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1. (NCT00107653) | Hoffmann-La Roche | 2004-10-01 |
| A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment (NCT00551174) | Hoffmann-La Roche | 2004-10-01 |
| A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia (NCT02569515) | Hoffmann-La Roche | 2004-10-01 |
| A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer (NCT02567331) | Hoffmann-La Roche | 2004-10-01 |
| A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer (NCT00087620) | Hoffmann-La Roche | 2004-09-01 |
| A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) (NCT02731131) | Hoffmann-La Roche | 2004-09-01 |
| A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis (NCT00683969) | Hoffmann-La Roche | 2004-08-01 |
| A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis (NCT02598934) | Hoffmann-La Roche | 2004-08-01 |
| A Study of Induction Dosing With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C (CHC) Genotype 1 Infection (NCT00192647) | Hoffmann-La Roche | 2004-08-01 |
| A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1 (NCT00100984) | Hoffmann-La Roche | 2004-07-21 |
| A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients (NCT00089492) | Hoffmann-La Roche | 2004-07-01 |
| A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis (NCT00081471) | Hoffmann-La Roche | 2004-06-01 |
| A Study of Epoetin Beta (NeoRecormon) in Participants With Solid Tumors (NCT02554942) | Hoffmann-La Roche | 2004-06-01 |
| A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia (NCT02604836) | Hoffmann-La Roche | 2004-06-01 |
| A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy (NCT00738530) | Hoffmann-La Roche | 2004-06-01 |
| A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies (NCT02097745) | Hoffmann-La Roche | 2004-06-01 |
| QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection (NCT00232908) | Hoffmann-La Roche | 2004-06-01 |
| A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis. (NCT00408213) | Hoffmann-La Roche | 2004-06-01 |
| A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients (NCT00081484) | Hoffmann-La Roche | 2004-06-01 |
| HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD) (NCT02806505) | Hoffmann-La Roche | 2004-06-01 |
| Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation (NCT00087581) | Hoffmann-La Roche | 2004-06-01 |
| A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) (NCT00683930) | Hoffmann-La Roche | 2004-05-01 |
| A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva (NCT00081653) | Hoffmann-La Roche | 2004-05-01 |
| A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients (NCT00090766) | Hoffmann-La Roche | 2004-05-01 |
| A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer (NCT00337649) | Hoffmann-La Roche | 2004-05-01 |
| A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT01996332) | Hoffmann-La Roche | 2004-04-01 |
| VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients (NCT00431353) | Hoffmann-La Roche | 2004-04-01 |
| A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis (NCT02598440) | Hoffmann-La Roche | 2004-03-01 |
| To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer (NCT02846428) | Hoffmann-La Roche | 2004-03-01 |
| A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients. (NCT00077623) | Hoffmann-La Roche | 2004-03-01 |
| A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. (NCT00077766) | Hoffmann-La Roche | 2004-03-01 |
| A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy (NCT02761642) | Hoffmann-La Roche | 2004-02-29 |
| A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors (NCT02490475) | Hoffmann-La Roche | 2004-02-01 |
| A Study of Mircera for the Treatment of Anemia in Dialysis Patients (NCT00077597) | Hoffmann-La Roche | 2004-02-01 |
| A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants (NCT02554955) | Hoffmann-La Roche | 2004-02-01 |
| A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients (NCT00077610) | Hoffmann-La Roche | 2004-02-01 |
| A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection (NCT02582983) | Hoffmann-La Roche | 2004-02-01 |
| A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment (NCT02864199) | Hoffmann-La Roche | 2004-02-01 |
| A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL) (NCT01144364) | Hoffmann-La Roche | 2004-01-19 |
| A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression (NCT02005484) | Hoffmann-La Roche | 2004-01-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). (NCT00077649) | Hoffmann-La Roche | 2004-01-01 |
| A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies (NCT02829775) | Hoffmann-La Roche | 2004-01-01 |
| A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors (NCT02494596) | Hoffmann-La Roche | 2004-01-01 |
| Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC). (NCT00087607) | Hoffmann-La Roche | 2004-01-01 |
| ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection. (NCT00077636) | Hoffmann-La Roche | 2003-12-01 |
| A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV) (NCT02604823) | Hoffmann-La Roche | 2003-11-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. (NCT00087594) | Hoffmann-La Roche | 2003-11-01 |
| A Study of Pertuzumab in Participants With Prostate Cancer (NCT02480010) | Hoffmann-La Roche | 2003-09-01 |
| A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials (NCT01853254) | Hoffmann-La Roche | 2003-09-01 |
| Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML) (NCT02736721) | Hoffmann-La Roche | 2003-09-01 |
| REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy (NCT00087646) | Hoffmann-La Roche | 2003-09-01 |
| Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients (NCT00121810) | Hoffmann-La Roche | 2003-08-01 |
| FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients (NCT00090051) | Hoffmann-La Roche | 2003-07-31 |
| A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer (NCT00077857) | Hoffmann-La Roche | 2003-07-01 |
| A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer (NCT00069095) | Hoffmann-La Roche | 2003-07-01 |
| A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine (NCT00468754) | Hoffmann-La Roche | 2003-07-01 |
| Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia (NCT00281918) | Hoffmann-La Roche | 2003-07-01 |
| A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (NCT00069108) | Hoffmann-La Roche | 2003-07-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C. (NCT00475072) | Hoffmann-La Roche | 2003-06-01 |
| A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy (NCT02767765) | Hoffmann-La Roche | 2003-06-01 |
| Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus (NCT00057304) | Hoffmann-La Roche | 2003-06-01 |
| A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) (NCT02641379) | Hoffmann-La Roche | 2003-05-01 |
| A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy (NCT00468546) | Hoffmann-La Roche | 2003-05-01 |
| Safety, Tolerability and Pharmacokinetics of Oral CellCept (Mycophenolate Mofetil) in Pediatric Liver Transplant Recipients on Concomitant Treatment With Cyclosporine and Corticosteroids (NCT02630563) | Hoffmann-La Roche | 2003-05-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3 (NCT01258101) | Hoffmann-La Roche | 2003-05-01 |
| A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer (NCT00069121) | Hoffmann-La Roche | 2003-04-18 |
| A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax) (NCT02576145) | Hoffmann-La Roche | 2003-04-01 |
| A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer (NCT02563054) | Hoffmann-La Roche | 2003-04-01 |
| A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer (NCT02565641) | Hoffmann-La Roche | 2003-03-01 |
| A Study of Pertuzumab in Participants With Metastatic Breast Cancer (NCT02491892) | Hoffmann-La Roche | 2003-02-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin (NCT00087568) | Hoffmann-La Roche | 2003-01-01 |
| Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma (NCT00048022) | Hoffmann-La Roche | 2002-10-25 |
| Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids (NCT00048009) | Hoffmann-La Roche | 2002-10-25 |
| A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma (NCT01609010) | Hoffmann-La Roche | 2002-10-01 |
| A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C (NCT00940420) | Hoffmann-La Roche | 2002-10-01 |
| (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy (NCT00354341) | Hoffmann-La Roche | 2002-09-01 |
| Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) (NCT02093026) | Hoffmann-La Roche | 2002-08-01 |
| A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer (NCT00089479) | Hoffmann-La Roche | 2002-08-01 |
| Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults (NCT02706067) | Hoffmann-La Roche | 2002-07-01 |
| DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis (NCT00048074) | Hoffmann-La Roche | 2002-06-01 |
| A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C (NCT00922779) | Hoffmann-La Roche | 2002-06-01 |
| A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer (NCT01998906) | Hoffmann-La Roche | 2002-05-01 |
| MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis (NCT00048061) | Hoffmann-La Roche | 2002-04-01 |